Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant Hepatitis B Vaccine market report explains the definition, types, applications, major countries, and major players of the Recombinant Hepatitis B Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck
Emergent Biosolutions
Serum Institute of India
Hualan Biological Engineering
Johnson & Johnson
China National Biotec Group
NCPC
Sanofi Pasteur
Dalian Hissen Bio-pharm
CSL Limited
GlaxoSmithKline Plc
Pfizer Inc
Beijing Tiantan Biological
By Type:
10mcg/ml
10mcg/05ml
By End-User:
Newborn
Primary School Students
Adult
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Recombinant Hepatitis B Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Recombinant Hepatitis B Vaccine Outlook to 2028- Original Forecasts
-
2.2 Recombinant Hepatitis B Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Recombinant Hepatitis B Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Recombinant Hepatitis B Vaccine Market- Recent Developments
-
6.1 Recombinant Hepatitis B Vaccine Market News and Developments
-
6.2 Recombinant Hepatitis B Vaccine Market Deals Landscape
7 Recombinant Hepatitis B Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Recombinant Hepatitis B Vaccine Key Raw Materials
-
7.2 Recombinant Hepatitis B Vaccine Price Trend of Key Raw Materials
-
7.3 Recombinant Hepatitis B Vaccine Key Suppliers of Raw Materials
-
7.4 Recombinant Hepatitis B Vaccine Market Concentration Rate of Raw Materials
-
7.5 Recombinant Hepatitis B Vaccine Cost Structure Analysis
-
7.5.1 Recombinant Hepatitis B Vaccine Raw Materials Analysis
-
7.5.2 Recombinant Hepatitis B Vaccine Labor Cost Analysis
-
7.5.3 Recombinant Hepatitis B Vaccine Manufacturing Expenses Analysis
8 Global Recombinant Hepatitis B Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Recombinant Hepatitis B Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Recombinant Hepatitis B Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Recombinant Hepatitis B Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Hepatitis B Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 10mcg/ml Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 10mcg/05ml Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Hepatitis B Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Newborn Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Primary School Students Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Adult Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Recombinant Hepatitis B Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.2.2 Canada Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.2 UK Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.3 Spain Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.5 France Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.6 Italy Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.8 Finland Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.9 Norway Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.11 Poland Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.12 Russia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.2 Japan Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.3 India Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.3 Chile Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.6 Peru Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6.3 Oman Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Recombinant Hepatitis B Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Recombinant Hepatitis B Vaccine Consumption (2017-2022)
11 Global Recombinant Hepatitis B Vaccine Competitive Analysis
-
11.1 Merck
-
11.1.1 Merck Company Details
-
11.1.2 Merck Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.1.4 Merck Recombinant Hepatitis B Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Emergent Biosolutions
-
11.2.1 Emergent Biosolutions Company Details
-
11.2.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.2.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Serum Institute of India
-
11.3.1 Serum Institute of India Company Details
-
11.3.2 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Serum Institute of India Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.3.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Hualan Biological Engineering
-
11.4.1 Hualan Biological Engineering Company Details
-
11.4.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.4.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Johnson & Johnson
-
11.5.1 Johnson & Johnson Company Details
-
11.5.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.5.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 China National Biotec Group
-
11.6.1 China National Biotec Group Company Details
-
11.6.2 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 China National Biotec Group Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.6.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 NCPC
-
11.7.1 NCPC Company Details
-
11.7.2 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 NCPC Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.7.4 NCPC Recombinant Hepatitis B Vaccine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sanofi Pasteur
-
11.8.1 Sanofi Pasteur Company Details
-
11.8.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.8.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Dalian Hissen Bio-pharm
-
11.9.1 Dalian Hissen Bio-pharm Company Details
-
11.9.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.9.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 CSL Limited
-
11.10.1 CSL Limited Company Details
-
11.10.2 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 CSL Limited Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.10.4 CSL Limited Recombinant Hepatitis B Vaccine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline Plc
-
11.11.1 GlaxoSmithKline Plc Company Details
-
11.11.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.11.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Pfizer Inc
-
11.12.1 Pfizer Inc Company Details
-
11.12.2 Pfizer Inc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Pfizer Inc Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.12.4 Pfizer Inc Recombinant Hepatitis B Vaccine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Beijing Tiantan Biological
-
11.13.1 Beijing Tiantan Biological Company Details
-
11.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Recombinant Hepatitis B Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Newborn Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Primary School Students Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Adult Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Recombinant Hepatitis B Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Recombinant Hepatitis B Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Recombinant Hepatitis B Vaccine
-
Figure of Recombinant Hepatitis B Vaccine Picture
-
Table Global Recombinant Hepatitis B Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Recombinant Hepatitis B Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 10mcg/ml Consumption and Growth Rate (2017-2022)
-
Figure Global 10mcg/05ml Consumption and Growth Rate (2017-2022)
-
Figure Global Newborn Consumption and Growth Rate (2017-2022)
-
Figure Global Primary School Students Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Table North America Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure United States Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure Germany Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure China Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Recombinant Hepatitis B Vaccine Consumption by Country (2017-2022)
-
Figure Australia Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Recombinant Hepatitis B Vaccine Consumption and Growth Rate (2017-2022)
-
Table Merck Company Details
-
Table Merck Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Merck Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Emergent Biosolutions Company Details
-
Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Serum Institute of India Company Details
-
Table Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Hualan Biological Engineering Company Details
-
Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolio
-
Table China National Biotec Group Company Details
-
Table China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table China National Biotec Group Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolio
-
Table NCPC Company Details
-
Table NCPC Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table NCPC Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table NCPC Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Sanofi Pasteur Company Details
-
Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Dalian Hissen Bio-pharm Company Details
-
Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolio
-
Table CSL Limited Company Details
-
Table CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table CSL Limited Recombinant Hepatitis B Vaccine Product Portfolio
-
Table GlaxoSmithKline Plc Company Details
-
Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Pfizer Inc Recombinant Hepatitis B Vaccine Product Portfolio
-
Table Beijing Tiantan Biological Company Details
-
Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Main Business and Markets Served
-
Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolio
-
Figure Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Newborn Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary School Students Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Recombinant Hepatitis B Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Recombinant Hepatitis B Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
